Author: 3M Company
Publisher: 3m Company
ISBN:
Category : 3M Company
Languages : en
Pages : 246

Get Book Here

Book Description
A compilation of 3M voices, memories, facts and experiences from the company's first 100 years.

Author: Muhammad H. Zaman
Publisher: Oxford University Press
ISBN: 0190219459
Category : Science
Languages : en
Pages : 281

Get Book Here

Book Description
Long the scourge of developing countries, fake pills are now increasingly common in the United States. The explosion of Internet commerce, coupled with globalization and increased pharmaceutical use has led to an unprecedented vulnerability in the U.S. drug supply. Today, an estimated 80% of our drugs are manufactured overseas, mostly in India and China. Every link along this supply chain offers an opportunity for counterfeiters, and increasingly, they are breaking in. In 2008, fake doses of the blood thinner Heparin killed 81 people worldwide and resulted in hundreds of severe allergic reactions in the United States. In 2012, a counterfeit version of the cancer drug Avastin, containing no active chemotherapy ingredient, was widely distributed in the United States. In early 2013, a drug trafficker named Francis Ortiz Gonzalez was sentenced to prison for distributing an assortment of counterfeit, Chinese-made pharmaceuticals across America. By the time he was arrested, he had already sold over 140,000 fake pills to customers. Even when the U.S. system works, as it mostly does, consumers are increasingly circumventing the safeguards. Skyrocketing health care costs in the U.S. have forced more Americans to become "medical tourists" seeking drugs, life-saving treatments and transplants abroad, sometimes in countries with rampant counterfeit drug problems and no FDA. Bitter Pills will heighten the public's awareness about counterfeit drugs, critically examine possible solutions, and help people protect themselves. Author Muhammad H. Zaman pays special attention to the science and engineering behind both counterfeit and legitimate drugs, and the role of a "technological fix" for the fake drug problem. Increasingly, fake drugs affect us all.

Author: Management Association, Information Resources
Publisher: IGI Global
ISBN: 1522562028
Category : Business & Economics
Languages : en
Pages : 352

Get Book Here

Book Description
Digital technology has revitalized the landscape of the global economy. As digital currency, such as bitcoin and IOTA, continues to become more prominent in society, conducting further research in this area is vital to promoting economic advancements. Digital Currency: Breakthroughs in Research and Practice is a critical source of academic knowledge on the use of computers, smartphones, and the internet to purchase goods and services using virtual currency. The security and privacy aspects of using digital currency are also explored. Highlighting a range of pertinent topics such as electronic commerce, online transaction payment, and web-based electronic money, this book is an ideal reference source for business executives, financial analysts, business professionals, economists, IT professionals, and researchers interested in emerging trends in digital currency and finance.

Author:
Publisher:
ISBN:
Category : Taiwan
Languages : en
Pages : 768

Get Book Here

Book Description

Author: Maki Yoshida
Publisher: Springer
ISBN: 3319098438
Category : Computers
Languages : en
Pages : 297

Get Book Here

Book Description
This book constitutes the refereed proceedings of the 9th International Workshop on Security, IWSEC 2014, held in Hirosaki, Japan, in August 2014. The 13 regular papers presented together with 8 short papers in this volume were carefully reviewed and selected from 55 submissions. The focus of the workshop was on the following topics: system security, threshold cryptography, hardware security, foundation, and encryption.

Author: Chris Ategeka
Publisher: John Wiley & Sons
ISBN: 1119817595
Category : Business & Economics
Languages : en
Pages : 295

Get Book Here

Book Description
Discover the technologies and trends that threaten humanity and our planet--- and how we can rein them back in, together In The Unintended Consequences of Technology: Solutions, Breakthroughs and the Restart We Need, accomplished tech entrepreneur Chris Ategeka delivers an insightful and eye-opening exploration of the challenges and the opportunities at the intersection of technology, society and our planet. Detailing both positive and negative technology use cases that on one hand have made humanity better, but on the other hand pose a serious threat to individuals and groups across the world, the author demonstrates how to avoid allowing powerful technologies to overcome our better natures. In this book, you'll: Discover how the forces of capitalism, greed and the myths that surround meritocracy when combined with exponential technology pose an existential risk for humanity. Explore the many exponential technologies such as gene editing, 5G, behavior modification, cyberspace… that have lots of promise but also uncertainty. Consider the future of humanity we wish to collectively build, and whether we can rebuild a capacity for empathy at scale in our tech tools Perfect for founders, business leaders, executives, managers, Chief Technology Officers, and anyone else [i.e. all human beings] responsible for the use and proliferation of advanced technologies. The Unintended Consequences of Technology is a thought-provoking, must-read resource for those at the forefront of our new technological reality.

Author: Helen Zhang
Publisher: Trans Tech Publications Ltd
ISBN: 3038136255
Category : Technology & Engineering
Languages : en
Pages : 794

Get Book Here

Book Description
Selected, peer reviewed papers from the 2011 International Conference on Material Engineering, Chemistry, Bioinformatics, MECB, August 21-22, 2011, Wuhan, China

Author:
Publisher:
ISBN:
Category : Paper industry
Languages : en
Pages : 490

Get Book Here

Book Description

Author: Dong Yang
Publisher: AuthorHouse
ISBN: 1728392756
Category : Business & Economics
Languages : en
Pages : 408

Get Book Here

Book Description
Blockchain technology is one of the most popular technologies in the recent decade. In 2008, Satoshi Nakamoto published a paper entitled Bitcoin: A Peer-to-Peer Electronic Cash System. This paper was the starting point of this technology. As of 2017, it has been nine years since blockchain’s development. During these years, blockchain has gradually developed toward industrialization from the initial technology boom. Although cryptocurrency and virtual currency transactions represented by Bitcoin fell to the bottom from the peak period of speculation in 2014, the investment of the relevant industries of blockchain in the world still rose gradually. With the deepening commercialization, the application of blockchain has been pervasive and has involved the financial sector and many other fields other than finance. Blockchain technology has revolutionized our day-to-day lives, and mass adoption of decentralized technology is predicted to happen shortly. This book has carried out valuable research in the provision of laws, rules, and systems in financial technology to make up for the shortcomings of existing research. At the same time, the book provides a large number of cases to explain how blockchain will fall, as well as the possible legal issues in landing. Blockchain and tokenomics are legal monographs in the blockchain industry that bridge the gaps in the legal reference of current blockchain business practices. This book will enable blockchain investors, blockchain entrepreneurs, and blockchain application explorers to understand the current and future practices of blockchain applications in a more transparent, more intuitive, and more comprehensive way by knowing the existing legal oversight and the future possibilities under the supervision of the work of blockchain.

Author: Beate Bittner
Publisher: Academic Press
ISBN: 0128237422
Category : Medical
Languages : en
Pages : 230

Get Book Here

Book Description
Today, the pressure on healthcare costs and resources is increasing, and especially for biopharmaceuticals that require parenteral administration, the inherent complex and invasive dosing procedure adds to the demand for efficient medical management. In light of the COVID-19 pandemic the value of drug delivery technologies in enabling a flexible care setting is broadly recognized. In such a setting, patients and their caregivers can choose the place of drug administration based on individual preferences and capabilities. This includes not only dosing in the clinic but also supervised at-home dosing and self-administration for eligible patients. Formulation and Device Lifecycle Management of Biotherapeutics: A Guidance for Researchers and Drug Developers covers the various aspects of improving drug delivery of biological medicines with the ultimate goal to reduce dosing complexity associated with parenteral administration and, thus, enhance patient experience and drug administration-related healthcare capacity. The target audience are multidisciplinary researchers and drug developers in the pharmaceutical industry, biotech companies, and academia involved in formulation and device development. This includes pharmacology and medical experts in charge of generating nonclinical and clinical data to support approval of novel dosing regimens, and drug delivery scientists and engineers responsible for technical particulars of product optimizations. Moreover, professionals in market access and commercial functions are expected to benefit from the discussions about the impact of patient and healthcare provider needs and country-specific reimbursement models on realizing a truly convenient and cost and resource efficient drug delivery solution. - Summarizes formulation and device lifecycle management activities that enable customer-centric and sustainable drug delivery for biotherapeutics - Describes the pharmacokinetic-based clinical development pathway for subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies - Details established clinical development pathways supporting the approval of automated subcutaneous injection devices and proposes novel concepts - Discusses how to realize home- and self-administration of biotherapeutics in cancer care - Highlights aspects of multidisciplinary formulation and device lifecycle management that can be leveraged across different disease areas and introduces a decision architecture on when and how drug developers should embark into related development activities